Drug Development in Pre-Clinical Research

Before testing a drug in people, researchers must determine whether it's the potential to cause serious harm, also called toxicity. the 2 sorts of preclinical research are: In Vitro, In Vivo. Usually, preclinical studies aren't very large. However, these studies must provide detailed information on dosing and toxicity levels. After preclinical testing, researchers review their findings and choose whether the drug should be tested in people.

 

    Related Conference of Drug Development in Pre-Clinical Research

    April 11-12, 2024

    41th Global Nanotechnology Congress

    Amsterdam, Netherlands
    April 25-26, 2024

    36th Nano Congress for Future Advancements

    London, UK
    May 16-17, 2024

    27th World Nanotechnology Congress

    Rome, Italy

    Drug Development in Pre-Clinical Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in